Disc Medicine, Inc. Common Stock IRON
$79.83
+1.14%
at last close
Analyst Consensus
- Consensus Rating
- Buy (8 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $120.13
- Implied Upside
- +50.5%
- Price Target Range
- $92.00 – $170.00
- Analysts (12 mo)
- 8
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-10-20 | Morgan StanleySean Laaman |
Maintains | Overweight | $90 → $92 |
| 2026-10-20 | Truist SecuritiesDanielle Brill |
Maintains | Buy | $83 → $115 |
| 2026-10-20 | Wells FargoDerek Archila |
Maintains | Overweight | $86 → $124 |
| 2026-10-20 | WedbushDavid Nierengarten |
Maintains | Outperform | $100 → $110 |
| 2026-10-19 | BMO CapitalEvan David Seigerman |
Maintains | Outperform | $100 → $120 |
| 2026-10-19 | Cantor FitzgeraldKristen Kluska |
Maintains | Overweight | $125 → $170 |
| 2026-09-16 | Wells FargoDerek Archila |
Maintains | Overweight | $79 → $86 |
| 2026-09-10 | WedbushDavid Nierengarten |
Reiterates | Outperform | $100 |
| 2026-09-02 | WedbushDavid Nierengarten |
Maintains | Outperform | $88 → $100 |
| 2026-08-06 | HC Wainwright & Co.Douglas Tsao |
Maintains | Buy | $118 → $120 |
| 2026-06-16 | Morgan StanleySean Laaman |
Maintains | Overweight | $80 → $85 |
| 2026-06-10 | WedbushDavid Nierengarten |
Reiterates | Outperform | $88 |
| 2026-05-14 | Morgan StanleySean Laaman |
Maintains | Overweight | $75 → $80 |
| 2026-03-02 | Wells FargoDerek Archila |
Maintains | Overweight | $78 → $79 |
| 2026-02-27 | Truist SecuritiesDanielle Brill |
Maintains | Buy | $114 → $83 |
| 2026-02-17 | StifelStephen Willey |
Maintains | Buy | $125 → $110 |
| 2026-02-17 | Cantor FitzgeraldKristen Kluska |
Maintains | Overweight | $153 → $125 |
| 2026-02-17 | BMO CapitalEvan David Seigerman |
Maintains | Outperform | $120 → $100 |
| 2026-02-17 | WedbushDavid Nierengarten |
Maintains | Outperform | $110 → $88 |
| 2026-02-17 | Wells FargoDerek Archila |
Maintains | Overweight | $109 → $78 |
| 2025-12-16 | Wells FargoDerek Archila |
Maintains | Overweight | $91 → $109 |
| 2025-11-10 | Truist SecuritiesDanielle Brill |
Maintains | Buy | $86 → $114 |
| 2025-11-03 | StifelStephen Willey |
Reinstates | Buy | $125 |
| 2025-10-30 | Morgan StanleySean Laaman |
Maintains | Overweight | $90 → $115 |
| 2025-10-17 | Raymond JamesMartin Auster |
Maintains | Strong buy | $89 → $108 |
| 2025-10-17 | Cantor FitzgeraldKristen Kluska |
Maintains | Overweight | $132 → $153 |
| 2025-10-17 | WedbushDavid Nierengarten |
Maintains | Outperform | $90 → $110 |
| 2025-08-18 | Morgan StanleySean Laaman |
Maintains | Overweight | $85 → $90 |
| 2025-07-21 | Truist SecuritiesDanielle Brill |
Initiates coverage on | Buy | $86 |
| 2025-07-03 | Morgan StanleySean Laaman |
Assumes | Overweight | $85 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $79.83
- Market Cap
- $3.03 billion
- 52-Week Range
- $40.00 – $99.50
- Average Volume
- 919K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.